Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Intangibles (2017 - 2025)

Organogenesis Holdings (ORGO) has 9 years of Intangibles data on record, last reported at $11.6 million in Q1 2025.

  • For Q1 2025, Intangibles fell 22.34% year-over-year to $11.6 million; the TTM value through Mar 2025 reached $11.6 million, down 22.34%, while the annual FY2024 figure was $12.5 million, 21.44% down from the prior year.
  • Intangibles reached $11.6 million in Q1 2025 per ORGO's latest filing, down from $12.5 million in the prior quarter.
  • Across five years, Intangibles topped out at $28.1 million in Q2 2021 and bottomed at $11.6 million in Q1 2025.
  • Average Intangibles over 5 years is $18.5 million, with a median of $16.5 million recorded in 2023.
  • Peak YoY movement for Intangibles: skyrocketed 46.82% in 2021, then dropped 23.66% in 2023.
  • A 5-year view of Intangibles shows it stood at $25.7 million in 2021, then decreased by 19.02% to $20.8 million in 2022, then decreased by 23.66% to $15.9 million in 2023, then fell by 21.44% to $12.5 million in 2024, then fell by 6.75% to $11.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Intangibles were $11.6 million in Q1 2025, $12.5 million in Q4 2024, and $14.1 million in Q2 2024.